NCT03422263View on ClinicalTrials.gov

Performance Under SGLT-2-Inhibitors in Humans

CompletedOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
Diabetes Mellitus, Type 2
Trial Locations (1)

3963

Berner Klinik Montana, Crans-Montana

All Listed Sponsors
lead

Berner Klinik Montana

OTHER

NCT03422263 - Performance Under SGLT-2-Inhibitors in Humans | Biotech Hunter | Biotech Hunter